Ekonominiai rezultatai

Restrictive blood transfusion practices are associated with improved patient outcomes. (atsiveria naujas langas)

Goodnough LT, Maggio P, Hadhazy E, Shieh L, Hernandez-Boussard T, Khari P, Shah N.

Šaltinis‎: Transfusion 2014;54(10 Pt 2):2753-9.

Kodas‎: PubMed 24995770

DOI‎: 10.1111/trf.12723

https://www.ncbi.nlm.nih.gov/pubmed/24995770 (atsiveria naujas langas)

Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. (atsiveria naujas langas)

Leahy MF, Hofmann A, Towler S, Trentino KM, Burrows SA, Swain SG, Hamdorf J, Gallagher T, Koay A, Geelhoed GC, Farmer SL.

Šaltinis‎: Transfusion 2017;57(6):1347-58.

Kodas‎: PubMed 28150313

DOI‎: 10.1111/trf.14006

https://www.ncbi.nlm.nih.gov/pubmed/28150313 (atsiveria naujas langas)

Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients. (atsiveria naujas langas)

MacLaren R, Sullivan PW.

Šaltinis‎: Value Health 2005;8(2):105-16.

Kodas‎: PubMed 15804319

DOI‎: 10.1111/j.1524-4733.2005.04006.x

https://www.ncbi.nlm.nih.gov/pubmed/15804319 (atsiveria naujas langas)

Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (atsiveria naujas langas)

Mehra T, Seifert B, Bravo-Reiter S, Wanner G, Dutkowski P, Holubec T, Moos RM, Volbracht J, Manz MG, Spahn DR

Šaltinis‎: Transfusion 2015;55(12):2807-15.

Kodas‎: PubMed 26264557

DOI‎: 10.1111/trf.13260

https://www.ncbi.nlm.nih.gov/pubmed/26264557 (atsiveria naujas langas)

Trauma-induced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs. (atsiveria naujas langas)

Nardi G, Agostini V, Rondinelli B, Russo E, Bastianini B, Bini G, Bulgarelli S, Cingolani E, Donato A, Gambale G, Ranaldi G

Šaltinis‎: Crit Care 2015;19:83.

Kodas‎: PubMed 25880548

DOI‎: 10.1186/s13054-015-0817-9

https://www.ncbi.nlm.nih.gov/pubmed/25880548 (atsiveria naujas langas)

The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. (atsiveria naujas langas)

Roberts I, Shakur H, Coats T, Hunt B, Balogun E, Barnetson L, Cook L, Kawahara T, Perel P, Prieto-Merino D, Ramos M, Cairns J, Guerriero C.

Šaltinis‎: Health Technol Assess 2013;17(10):1-79.

Kodas‎: PubMed 23477634

DOI‎: 10.3310/hta17100

https://www.ncbi.nlm.nih.gov/pubmed/23477634 (atsiveria naujas langas)

Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma. (atsiveria naujas langas)

Stein DM, Dutton RP, Kramer ME, Scalea TM.

Šaltinis‎: J Trauma 2009;66(1):63-72.

Kodas‎: PubMed 19131807

DOI‎: 10.1097/TA.0b013e318191bc8a

https://www.ncbi.nlm.nih.gov/pubmed/19131807 (atsiveria naujas langas)

Effect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: a model simulation. (atsiveria naujas langas)

Zilberberg MD, Shorr AF.

Šaltinis‎: BMC Health Serv Res 2007;7:138.

Kodas‎: PubMed 17764560

DOI‎: 10.1186/1472-6963-7-138

https://www.ncbi.nlm.nih.gov/pubmed/17764560 (atsiveria naujas langas)

INTENSYVIOJI IR KRITINĖ TERAPIJA

Ekonominiai rezultatai

lietuvių

Ekonominiai rezultatai

https://assetsnffrgf-a.akamaihd.net/assets/ct/d8f8c0370e/images/syn_placeholder_sqr.png

Restrictive blood transfusion practices are associated with improved patient outcomes. (atsiveria naujas langas)

Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. (atsiveria naujas langas)

Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients. (atsiveria naujas langas)

Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (atsiveria naujas langas)

Trauma-induced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs. (atsiveria naujas langas)

The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. (atsiveria naujas langas)

Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma. (atsiveria naujas langas)

Effect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: a model simulation. (atsiveria naujas langas)

Susisiekite su vietiniu atstovu

Medicininės informacijos paketai

Filmai

Ekonominiai rezultatai

Kalbos pasirinkimas

Dalintis